Medical (BELNUC award) |
3 awards |
- 1st price (400,- Euro) – Disturbing the redox balance as a new radiosensitizing strategy for Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. Wendy Delbart (Institut Jules Bordet, Anderlecht)
- 2nd price (200,- Euro) – [18F]AlF-NOTA-octreotide vs. [68Ga]Ga-DOTA-somatostatin analogue PET in neuroendocrine tumour patients: interim results of a prospective multicentre trial. Elin Pauwels (UZ Leuven, Leuven)
- 3rd price (100,- Euro) – Yttrium-90 radioembolization versus drug-eluting beads chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE trial. Bieke Lambert (UGent, Gent)
|
Young Nuclearist Challenge |
3 awards |
- 1st price (300,- Euro) – Breaking the oculo-(para)neoplastic reflex on FDG-PET/CT: cerebellar hypermetabolism in a Hodgkin lymphoma leads to an unexpected diagnosis. Eef Vanerwegen (Imelda Hospital, Bonheiden)
- 2nd price (200,- Euro) – The nerve-racking case of [18F]PSMA-1007 PET/CT in a patient with continuous low back pain. Anne-Leen Deleu (UZ Leuven, Leuven)
- 3rd price (100,- Euro) – Just a little RE(nal)SPECT. Geraldine Lens (UZ Leuven, Leuven)
|
Technologist |
4 awards |
- 1st price (250,- Euro) – Implementing Lutetium-177 PSMA ligand therapy: practical aspects concerning radioprotection and dosimetry – Luna Belmans, Atheneum Gentbrugge
- 2nd price (150,- Euro) – Logistical analysis of the individual “whole body” dosimetry of personnel professionally exposed to ionizing radiation in Belgium, over the last 10 years. Ana Mafalda Pereira Gomes (Vinçotte S.A, Vilvoorde)
- 3rd price (100,- Euro) – Design of an integrated Radiopharmaceutical Supply Chain (SC) to enhance its overall Supply Chain Performance Methodology. Haingo, Rabarijaona (Université Libre de Bruxelles, Brussels)
- 4th price (100,- Euro) – Can a third party software vendor (MIMVista) match the image quality of native software vendor? Bram Van Landeghem (AZ Jan Palfijn Gent, Ghent)
|
Radiochemistry and Radiopharmacy |
1 award |
- 1st price (400,- Euro) – Development and preclinical evaluation of [11C]HSP990 as an Hsp90 PET brain probe and potential biomarker for diagnosis and follow up of CNS disease progression. Romy Cools (Laboratory for Radiopharmaceutical Research KU Leuven, Leuven)
|
Physics and Engineering |
1 award |
- 1st price (400,- Euro) – Feasibility of lesion dosimetry assuming constant pharmacokinetics over cycles in patients treated with 177Lu-DOTATATE. Rachele Danieli (Institut Jules Bordet, Anderlecht)
|